Participated · Series C · Jun 2022

Cyberint provides external risk visibility and attack‑surface management by harvesting dark‑web data and autonomously analyzing potential vulnerabilities. The company’s platform is designed to help organizations identify exposures stemming from external threats and compromised assets. The article highlights Cyberint’s focus on dark‑web intelligence and autonomous analysis as core capabilities. Recently announced financing indicates an active capital position: a $28 million Series C alongside $12 million in credit. Menora Mivtachim Group publicized the round and emphasized partnership and investment in Cyberint. The article does not disclose revenue, user metrics, founding year, or location. CyberInt provides detection and response services through its Argos™ platform, addressing cyber, fraud, and brand threats for global omnichannel organizations. The Argos platform leverages artificial intelligence and machine learning and offers modular capabilities including Targeted Threat Intelligence, Social Media Monitoring, VIP Protection, Brand Protection, Vendor Risk Management, and Email Threat Management. The company pairs the platform with a global team of ex‑CISO, ex‑8200 and white‑hat hacker cyber experts located in Israel, New York, London, Singapore, and Manila. Led by CEO Amir Ofek, CyberInt serves customers across financial services, retail, eCommerce, and gaming. It completed an $18M financing to fund global expansion, expand Argos, and develop next‑generation Digital Risk Management, Detection and Response solutions.

Participated · Series C · Jul 2021

UVeye is an AI-driven vehicle inspection technology company that provides automated, data-driven diagnostics often described as an "MRI for vehicles". Its product suite includes underbody scanners, tire analyzers, and 360-degree exterior detection systems. Those systems have been installed at hundreds of dealerships, fleet sites, and auction lots globally. Clients include Amazon and General Motors. Led by CEO Amir Hever and based in Teaneck, NJ, the company raised $191M in the latest funding round, bringing total capital raised to $380.5M. UVeye plans to use the funds to expand globally, increase large-scale manufacturing capacity, and strengthen strategic partnerships. UVeye builds automated vehicle-inspection systems that use computer vision and machine learning to quickly and accurately inspect vehicles. The company produces three inspection systems: an underbody scanner, a tire system, and a 360-degree exterior system that can scan moving vehicles in seconds. Since its founding in 2016, UVeye has secured commercial agreements with OEMs and dealers including General Motors, Volvo Cars USA and CarMax and supports dealerships, auctions, insurance companies and commercial fleets. The company employs about 200 people and is based in New Jersey and Tel Aviv, with additional offices in Japan and Germany. UVeye plans to start production of its inspection systems in North America and accelerate sales growth to reach thousands of dealerships, used-car auctions and fleets within the next three years. Management sees longer-term opportunities serving EVs, autonomous and robotaxi fleets for safety and predictive maintenance by combining vehicle sensors with UVeye's capabilities. Financially, the company has raised roughly $200 million since 2016 and its valuation is about $800 million after the latest round. UVeye develops high-speed automated vehicle-inspection systems that combine proprietary algorithms, cloud architecture, artificial intelligence, machine learning and sensor fusion. Its drive-through scanners detect external and mechanical flaws, anomalies, modifications and foreign objects from under and from any side of a vehicle, completing scans within seconds and usable across a vehicle’s lifecycle. The technology was originally developed for the security industry to detect weapons and contraband and is now applied in the automotive industry to find quality issues such as oil leaks, paint scratches, tire damage, brake-line damage and exhaust-system problems. Founded in 2016 and based in Tel Aviv, Israel, UVeye operates facilities in North America, Europe and the Asia Pacific region, with offices in Israel, Japan, Germany and the U.S. The company has 100 employees. UVeye raised $60m in Series C funding and intends to use the proceeds for global expansion. UVeye develops automated vehicle-inspection systems that combine proprietary algorithms, cloud architecture, artificial intelligence, machine learning and sensor fusion to standardize and speed previously manual inspections. Its platforms serve both homeland security and automotive customers across the vehicle lifecycle, including supplier and OEM assembly lines, new-car showrooms, dealership service departments and used-vehicle auction sites. The company has installed systems at assembly plants, auction sites and dealerships around the world and has offices in Tel Aviv, Cleveland and New York, as well as locations in Japan and Germany. UVeye is led by CEO and co-founder Amir Hever and employs more than 100 people. The company says it will use the new funds to accelerate its global expansion plans and to enable Hyundai to deploy UVeye’s products across its operations worldwide. Since it was founded four years ago, UVeye has raised more than $40m from carmakers and other strategic investors including W. R. Berkley Corporation. UVeye develops vertically integrated drive-through scanning systems (hardware and software) that capture exterior, tire and undercarriage images and use computer vision and AI to detect anomalies. Its fully automated platform can read moving cars (up to ~20 mph) and detect cosmetic anomalies as small as 2 millimeters. Customers and use cases include OEMs, rental and used-car companies, insurers, security services, governments and ride-hailing fleets for inspections, claims and lifecycle management. The company is exploring deeper integration with vehicle diagnostics and potential expansion into interior/cargo scanning and logistics/security verticals. UVeye emphasizes full automation to replace manual inspections and continues to optimize its system and scale deployment to meet demand. Financially, the company has raised a new $31M round, bringing total capital raised to about $35M.

Participated · Series A · Jul 2021

NoTraffic develops an AI-powered mobility platform that connects and optimizes traffic signals as a cloud-based digital grid to improve efficiency, sustainability, and safety. The company operates a proactive Operations Center offering 24/7 monitoring, remote diagnostics, and over-the-air updates to support agency teams and deployments. Its platform has been adopted by traffic agencies across more than 40 U.S. states and Canada, including deployments in Houston, Phoenix, and Oklahoma. The company is led by CEO Tal Kreisler and is based in Overland Park, KS. Financially, NoTraffic recently completed a $90M Series C to fund expansion of operations and further product development.

Participated · Series C · Feb 2021

Medisafe builds medication-management digital drug companions and deploys AI-driven personalization (JITI™) to support patients across their therapy journeys. The platform has over 7M registered users and a database of more than four billion dosage behaviors that inform its Just-in-Time-Interventions engine. Medisafe partners with global pharma companies and is expanding opportunities across the broader health ecosystem. Product offerings include Medisafe Care Connector, launched in 2020 to link clinicians into patient support programs, and Maestro, a proprietary no-code technology for building and optimizing personalized journeys introduced last September. The company is led by CEO Omri Shor and was founded in 2012. It intends to use new funding to expand end-to-end solutions and accelerate revenue growth. Medisafe is a Boston-based personalized medication management platform that addresses major causes of medication non-adherence. Its cloud-based mobile platform personalizes content, resources and interventions, including educational videos, coupons and motivational messages, based on each user’s regimen, condition and circumstances. The platform runs on iOS and Android and has been used by over 3.5 million patient and caregiver registered users who have recorded over 500 million medication doses and contributed 140,000 app-store reviews. Led by CEO and co-founder Omri Shor, the company plans to use new funding to expand sales, marketing and engineering teams. Medisafe also intends to open a European office to support international growth. These moves are aimed at scaling operations and increasing adoption of its medication‑adherence tools. MediSafe is a mobile-first medication management platform that reminds patients to take medications and alerts caregivers when doses are missed. The company delivers personalized interventions addressing forgetfulness, lack of support, emotional distress, information overload, low engagement, and medication cost barriers. Its platform enables tighter care coordination between patients, “MedFriends” (caregivers), physicians, and other providers. MediSafe reports more than 1.3 million downloads across iOS and Android and about 52,000 ratings averaging 4.5 out of 5. The company has won multiple industry awards and recognition for its mHealth solution. MediSafe plans to expand its suite of medication-management solutions, enhance user experience in its apps, accelerate U.S. user growth, and pursue distribution, technology, and data partnerships as part of its market expansion. MediSafe provides a cloud-synced mobile medication management app that reminds patients when to take medications and sends alerts to caretakers if doses are missed. The platform anonymously aggregates de-identified, self-reported user data and reports an 86% adherence rate among its users. MediSafe plans to use recent funding to build partnership programs with pharmaceutical companies, pharmacies, HMOs, employers and hospitals to better manage medication adherence. The company positions its analytics to give healthcare leaders insight into patient behavior and the issue of non-adherence. MediSafe was co-founded in mid 2012, graduated from the Microsoft Ventures Accelerator, and has seen growth in user adoption and satisfaction. The $1 million funding is intended to support product enhancements, partnership development, and continued expansion of its analytics capabilities.